Originally Posted by bgbgbg
So it was two different incidents
ITF Press Release Decision in the case of Sesil Karatantcheva London, ENGLAND, 11 Jan 2006
- The International Tennis Federation announced today that an independent Anti-Doping Tribunal convened under the Tennis Anti-Doping Programme has found that Sesil Karatantcheva has committed a Doping Offence under the Programme.
The independent Anti-Doping Tribunal has ruled that Ms. Karatantcheva, a 16-year-old Bulgarian, has committed a Doping Offence under Article C.1 of the Programme (presence of a prohibited substance in a sample) in that a sample that she provided on 31 May 2005 at Roland Garros, and another conducted out of competition in Tokyo on 5 July 2005, tested positive for a steroid (nandrolone), a substance prohibited in competition under the WADA Code and the Tennis Anti-Doping Programme.
The independent Tribunal, consisting of Mr. Tim Kerr QC, Dr. Anik Sax and Professor Vivian James, heard the matter on 14-15 December 2005 in London. The Tribunal determined that a Prohibited Substance (nandrolone) had been present in a concentration above the reporting threshold in both the May and July samples. The Tribunal rejected the player’s defences but determined that the two offences would be treated as one single first offence for sanctioning purposes. The Tribunal therefore confirmed commission of a Doping Offence under Article C.1 of the Programme and automatically disqualified Ms. Karatantcheva’s results at Roland Garros, requiring forfeiture of entry ranking points and prize money (€110,370), as well as entry ranking points and prize money (US$128,897) from all competitions subsequent to 2005 Roland Garros. The Tribunal declares that the player shall be ineligible for a period of two years commencing 1 January 2006.
The Tribunal’s written decision with reasons will be available shortly as a PDF file below.
Any party wishing to appeal the decision will have three weeks to do so from receipt of the written decision.
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at tournaments sanctioned by the ITF, ATP and WTA Tour. The ITF tests at Grand Slams (men and women), Davis Cup and Fed Cup, ITF Men’s and Women’s Circuit, Junior and Wheelchair Tennis Events, and from 2006, manages the testing at all ATP-sanctioned events. The WTA Tour manages testing at WTA Tour events. Players are tested for substances prohibited by the World Anti-Doping Agency. Charges of breach of the Programme are heard by an independent Anti-Doping Tribunal.